Enteral glucose, absorbed and metabolized, potently enhances mesenteric lymph flow in chow- and high-fat-fed rats

Am J Physiol Gastrointest Liver Physiol. 2022 Oct 1;323(4):G331-G340. doi: 10.1152/ajpgi.00095.2022. Epub 2022 Aug 2.

Abstract

A portion of absorbed dietary triglycerides (TG) is retained in the intestine after the postprandial period, within intracellular and extracellular compartments. This pool of TG can be mobilized in response to several stimuli, including oral glucose. The objective of this study was to determine whether oral glucose must be absorbed and metabolized to mobilize TG in rats and whether high-fat feeding, a model of insulin resistance, alters the lipid mobilization response to glucose. Lymph flow, TG concentration, TG output, and apolipoprotein B48 (apoB48) concentration and output were assessed after an intraduodenal lipid bolus in rats exposed to the following intraduodenal administrations 5 h later: saline (placebo), glucose, 2-deoxyglucose (2-DG, absorbed but not metabolized), or glucose + phlorizin (intestinal glucose absorption inhibitor). Glucose alone, but not 2-DG or glucose + phlorizin treatments, stimulated lymph flow, TG output, and apoB48 output compared with placebo. The effects of glucose in high-fat-fed rats were similar to those in chow-fed rats. In conclusion, glucose must be both absorbed and metabolized to enhance lymph flow and intestinal lipid mobilization. This effect is qualitatively and quantitatively similar in high-fat- and chow-fed rats. The precise signaling mechanism whereby enteral glucose enhances lymph flow and mobilizes enteral lipid remains to be determined.NEW & NOTEWORTHY Glucose potently enhances mesenteric lymph flow in chow- and high-fat-fed rats. The magnitude of glucose effect on lymph flow is no different in chow- and high-fat-fed rats. Glucose must be absorbed and metabolized to enhance lymph flow and mobilize intestinal lipid.

Keywords: chylomicron; glucose; intestine; lymph; triglyceride.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apolipoprotein B-48
  • Chylomicrons* / metabolism
  • Deoxyglucose / metabolism
  • Deoxyglucose / pharmacology
  • Glucose* / metabolism
  • Lymph / metabolism
  • Phlorhizin / metabolism
  • Phlorhizin / pharmacology
  • Rats
  • Triglycerides / metabolism

Substances

  • Apolipoprotein B-48
  • Chylomicrons
  • Triglycerides
  • Deoxyglucose
  • Phlorhizin
  • Glucose

Associated data

  • figshare/10.6084/m9.figshare.20219934.v1

Grants and funding